Form 8-K - Current report:
SEC Accession No. 0001213900-25-008377
Filing Date
2025-01-30
Accepted
2025-01-30 16:10:52
Documents
16
Period of Report
2025-01-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0229135-8k_drugs.htm 8-K 37390
2 UNDERWRITING AGREEMENT, DATED JANUARY 27, 2025, BY AND BETWEEN THE COMPANY AND C ea022913501ex1-1_drugs.htm EX-1.1 244779
3 SECOND AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION ea022913501ex3-1_drugs.htm EX-3.1 341912
4 RIGHTS AGREEMENT, DATED JANUARY 7, 2025, BY AND BETWEEN THE COMPANY AND VSTOCK T ea022913501ex4-1_drugs.htm EX-4.1 68171
5 LETTER AGREEMENT, DATED JANUARY 7, 2025, BY AND AMONG THE COMPANY, DRUGS MADE IN ea022913501ex10-1_drugs.htm EX-10.1 46260
6 INVESTMENT MANAGEMENT TRUST AGREEMENT, DATED JANUARY 7, 2025, BY AND AMONG THE C ea022913501ex10-2_drugs.htm EX-10.2 104109
7 REGISTRATION RIGHTS AGREEMENT, DATED JANUARY 7, 2025, BY AND AMONG THE COMPANY A ea022913501ex10-3_drugs.htm EX-10.3 103717
8 AMENDED AND RESTATED PRIVATE UNITS SUBSCRIPTION AGREEMENT, DATED JANUARY 27, 202 ea022913501ex10-4_drugs.htm EX-10.4 25588
9 FORM OF INDEMNITY AGREEMENT BY AND BETWEEN THE COMPANY AND EACH OF THE OFFICERS ea022913501ex10-5_drugs.htm EX-10.5 81921
10 ADMINISTRATIVE SERVICES AGREEMENT, DATED AS OF JANUARY 7, 2025, BY AND BETWEEN T ea022913501ex10-6_drugs.htm EX-10.6 10843
11 NOTE CONVERSION AGREEMENT, DATED AS OF JANUARY 29, 2025, BY AND BETWEEN THE COMP ea022913501ex10-7_drugs.htm EX-10.7 19862
12 PROMISSORY NOTE, DATED AS OF JANUARY 29, 2025, ISSUED TO DRUGS MADE IN AMERICA A ea022913501ex10-8_drugs.htm EX-10.8 26140
13 PRESS RELEASE DATED JANUARY 27, 2025 ea022913501ex99-1_drugs.htm EX-99.1 8449
14 PRESS RELEASE DATED JANUARY 29, 2025 ea022913501ex99-2_drugs.htm EX-99.2 7942
15 GRAPHIC ex3-1_001.jpg GRAPHIC 17938
16 GRAPHIC ex3-1_002.jpg GRAPHIC 7532
  Complete submission text file 0001213900-25-008377.txt   1163745
Mailing Address 2 PELICAN DR. FORT LAUDERDALE FL 33301
Business Address 2 PELICAN DR. FORT LAUDERDALE FL 33301 954-870-3104
Drugs Made In America Acquisition Corp. (Filer) CIK: 0002028614 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42467 | Film No.: 25573828
SIC: 6770 Blank Checks
(CF Office: 05 Real Estate & Construction)